Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community (scientific article published on March 2009)

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Q27860959

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Q28186874

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Q29614698

Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress.

Q33954728

The Diabetes Prevention Program (DPP): description of lifestyle intervention

Q34130215

Genes, environment and Oji-Cree type 2 diabetes

Q35119581

Type 2 diabetes: principles of pathogenesis and therapy

Q36095054

Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial

Q36416919

Should we dump the metabolic syndrome? Yes.

Q36502707

Should we dump the metabolic syndrome? No.

Q36502715

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

Q36825706

The epidemiology of diabetes in the Manitoba-registered First Nation population: current patterns and comparative trends

Q40578060

Predicting future cardiovascular disease: do we need the oral glucose tolerance test?

Q40630393

The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population

Q43857804

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

Q43960351

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

Q44333600

Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose

Q44909462

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

Q46795016

Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study

Q46815611

The prevalence of NIDDM and associated risk factors in native Canadians.

Q50959947

Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study.

Q51038778

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

Q51482560

Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.

Q51498856

Incidence and prevalence of type 2 diabetes in the First Nation community of Kahnawá:ke, Quebec, Canada, 1986-2003.

Q51671970

Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents

Q57314351

The Metabolic Syndrome in American Indians: The Strong Heart Study

Q61868282

Increasing rates of ischemic heart disease in the native population of Ontario, Canada

Q73935055

Metabolic syndrome in American Indians

Q74373122

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

metabolic syndrome

Q657193

type 2 diabetes

Q3025883

P304

page(s)

617-624

P577

publication date

2009-03-01

P1433

published in

Canadian Medical Association Journal

Q5030320

P1476

title

Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community

P478

volume

180

Reverse relations

cites work (P2860)

Q91691519	A Scoping Review of Obesity among Indigenous Peoples in Canada
Q91844352	Association between Serum Ferritin and Blood Lipids: Influence of Diabetes and hs-CRP Levels
Q64137651	Association between serum magnesium and blood lipids: influence of type 2 diabetes and central obesity
Q37441909	Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population
Q36765727	Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study
Q34600040	Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian First Nation.
Q34877979	Excessive 5-year weight gain predicts metabolic syndrome development in healthy middle-aged adults
Q44365648	Family history of diabetes modifies the effect of blood pressure for incident diabetes in Middle Eastern women: Tehran Lipid and Glucose Study
Q45305959	Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Q33786252	HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study
Q34678656	Implementation of a lifestyle program in primary care by nurse practitioners
Q43710316	Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial
Q41706391	Incidence of metabolic syndrome and related diseases in the Khisêdjê indigenous people of the Xingu, Central Brazil, from 1999-2000 to 2010-2011.
Q35983431	Incident diabetes, hypertension and dyslipidemia in a Manitoba First Nation
Q89590994	Influence of Preexisting Diabetes on Survival After a Breast Cancer Diagnosis in First Nations Women in Ontario, Canada
Q37122880	Is diagnosing metabolic syndrome a uniquely simple way to predict incident type 2 diabetes mellitus?
Q60956865	Metabolic Syndrome and Its Components Predict the Risk of Type 2 Diabetes Mellitus in the Mainland Chinese: A 3-Year Cohort Study
Q90746538	Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study
Q33644612	Metabolic syndrome and the early detection of impaired glucose tolerance among professionals living in Beijing, China: a cross sectional study
Q33607601	Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness
Q88064176	Non-high-density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance
Q37120686	Preliminary analysis of immune activation in early onset type 2 diabetes
Q36861098	Prevalence of metabolic syndrome and diabetes mellitus in Sami and Norwegian populations. The SAMINOR-a cross-sectional study
Q36082229	Regardless of central obesity, metabolic syndrome is a significant predictor of type 2 diabetes in Japanese Americans
Q42375184	Relation of four nontraditional lipid profiles to diabetes in rural Chinese H-type hypertension population
Q35095114	Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
Q37298494	Sandy lake health and diabetes project: a community-based intervention targeting type 2 diabetes and its risk factors in a first nations community
Q34600964	Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy
Q35500732	The burden of cancer risk in Canada's indigenous population: a comparative study of known risks in a Canadian region
Q37280841	Traditional foods and 25(OH)D concentrations in a subarctic First Nations community
Q47892957	Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk